OrbiMed Israel GP II, L.P. insider trades: ADARx Pharmaceuticals (ADRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where OrbiMed Israel GP II, L.P. reports to the SEC
and 1 more company
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | ADRX | ↑ Buy | 950,000 | $17.00 | $16.1M | Indirect | Sep 30, 2026 (2d) |
| Apr 8, 2026 | ACET | ↓ Sell | 104,658 | $6.45 | $675K | Indirect | Apr 9, 2026 (1d) |
| Oct 8, 2025 | ACET | ↑ Buy | 5,000,000 | $1.00 | $5.0M | Indirect | Oct 10, 2025 (2d) |
| Oct 15, 2024 | UPB | ↑ Buy | 825,000 | $17.00 | $14.0M | Indirect | Oct 17, 2024 (2d) |
| Jan 25, 2024 | ACET | ↑ Buy | 3,125,000 | $2.40 | $7.5M | Indirect | Jan 26, 2024 (1d) |
| Aug 15, 2023 | GLTO | ↓ Sell | 822,680 | $0.75 | $617K | Indirect | Aug 17, 2023 (2d) |
| Jul 31, 2023 | GLTO | ↓ Sell | 209,400 | $3.00 | $628K | Indirect | Aug 2, 2023 (2d) |
| Jul 25, 2023 | GLTO | ↓ Sell | 39,200 | $2.92 | $114K | Indirect | Jul 27, 2023 (2d) |
| Jul 13, 2023 | GLTO | ↓ Sell | 194,700 | $2.40 | $467K | Indirect | Jul 17, 2023 (4d) |
| Jun 27, 2023 | ACET | ↑ Buy | 875,000 | $2.09 | $1.8M | Indirect | Jun 29, 2023 (2d) |
| Apr 17, 2023 | GLTO | ↓ Sell | 68,481 | $1.87 | $128K | Indirect | Apr 17, 2023 (0d) |
| Apr 12, 2023 | GLTO | ↓ Sell | 67,537 | $1.80 | $121K | Indirect | Apr 12, 2023 (0d) |
| Apr 6, 2023 | GLTO | ↓ Sell | 102,630 | $2.16 | $222K | Indirect | Apr 7, 2023 (1d) |
| Jan 26, 2022 | ETNB | ↓ Sell | 70,573 | $8.39 | $592K | Indirect | Jan 27, 2022 (1d) |
| Nov 2, 2020 | GLTO | ↑ Buy | 733,333 | $15.00 | $11.0M | Indirect | Nov 4, 2020 (2d) |
| Oct 1, 2020 | LOGC | ↑ Buy | 1,481,482 | $6.00 | $8.9M | Indirect | Oct 5, 2020 (4d) |
| Sep 21, 2020 | ETNB | ↓ Sell | 137,500 | $28.00 | $3.9M | Indirect | Sep 23, 2020 (2d) |
| Nov 11, 2019 | ETNB | ↑ Buy | 418,750 | $16.00 | $6.7M | Indirect | Nov 13, 2019 (2d) |
| Oct 23, 2018 | LOGC | ↑ Buy | 1,190,000 | $10.00 | $11.9M | Indirect | Oct 25, 2018 (2d) |
| Aug 30, 2018 | STDY | ↓ Sell | 2,123,098 | $4.46 | $9.5M | Indirect | Sep 7, 2018 (8d) |
| Apr 25, 2017 | STDY | ↑ Buy | 587,000 | $5.90 | $3.5M | Indirect | Apr 27, 2017 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ADRX insiders
Open-market trades in the last 12 months
About OrbiMed Israel GP II, L.P.'s insider trades
OrbiMed Israel GP II, L.P. is a director at ADARx Pharmaceuticals (ADRX). Since Apr 25, 2017, it has reported 10 open-market purchases worth $86.5M and 11 sales worth $16.9M on SEC Form 4. In the last 12 months: 1 buy ($16.1M) and 1 sale ($675K).
Its filings also include conversions (5 filings), grants and awards (4 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.